Haleon plc (NYSE:HLN) Shares Sold by U.S. Capital Wealth Advisors LLC

U.S. Capital Wealth Advisors LLC lessened its holdings in shares of Haleon plc (NYSE:HLN) by 2.6% during the 4th quarter, Holdings Channel reports. The firm owned 131,534 shares of the company’s stock after selling 3,482 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in Haleon were worth $1,083,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in HLN. FMR LLC increased its stake in shares of Haleon by 22.2% during the third quarter. FMR LLC now owns 53,951,936 shares of the company’s stock worth $449,420,000 after buying an additional 9,812,040 shares during the period. Wellington Management Group LLP purchased a new position in Haleon in the third quarter valued at approximately $42,640,000. Envestnet Asset Management Inc. increased its stake in Haleon by 121.2% in the third quarter. Envestnet Asset Management Inc. now owns 5,931,187 shares of the company’s stock valued at $49,407,000 after purchasing an additional 3,249,517 shares during the last quarter. Cambiar Investors LLC purchased a new position in Haleon in the fourth quarter valued at approximately $15,225,000. Finally, Kayne Anderson Rudnick Investment Management LLC increased its stake in Haleon by 6,593.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,692,937 shares of the company’s stock valued at $14,102,000 after purchasing an additional 1,667,643 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Argus reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. HSBC assumed coverage on shares of Haleon in a research report on Wednesday, April 17th. They set a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Haleon has an average rating of “Moderate Buy”.

Haleon Trading Down 0.5 %

Shares of Haleon stock opened at $8.26 on Monday. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The firm has a market cap of $37.72 billion, a price-to-earnings ratio of 27.67, a price-to-earnings-growth ratio of 2.19 and a beta of 0.28. Haleon plc has a 52-week low of $7.70 and a 52-week high of $8.98. The company’s 50-day simple moving average is $8.33 and its 200-day simple moving average is $8.29.

Haleon Dividend Announcement

The firm also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Stockholders of record on Friday, March 15th will be paid a dividend of $0.1064 per share. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon’s dividend payout ratio (DPR) is 70.00%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.